Document is current
Any future updates will be listed below
-
Authors
Johnson, Erik C. B.
Ho, Kaitlyn
Yu, Gui-Qiu
Das, Melanie
Sanchez, Pascal E.
Djukic, Biljana
Lopez, Isabel
Yu, Xinxing
Gill, Michael
Zhang, Weiping
Paz, Jeanne T.
Palop, Jorge J.
Mucke, Lennart https://orcid.org/0000-0001-6256-9559
-
Funding
Funding for this research was provided by:
National Institutes of Health (AG011385)
National Institutes of Health (AG054304)
National Institutes of Health (AG047313)
National Institutes of Health (AG062234)
National Institutes of Health (OD021717)
Ray and Dagmar Dolby Family Fund (gift)
- License Information
-
More Information
Article History
Received: 22 July 2019
Accepted: 8 July 2020
First Online: 14 September 2020
Ethics approval and consent to participate
: All studies involving animals were in accordance with NIH guidelines and all procedures were approved by the UCSF Institutional Animal Care and Use Committee.
: Not applicable.
: PES is now employed by Denali Therapeutics. LM has served as a consultant or advisory board member for Abingworth, Alkahest, Arvinas, Biogen, Dolby Family Ventures, Eisai, and Sangamo Therapeutics.
